BENZPYRINIUM BROMIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H17N2O2.Br
Molecular Weight	337.212
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Br-].CN(C)C(=O)OC1=C[N+](CC2=CC=CC=C2)=CC=C1

InChI

InChIKey=YIUNVJGEMXODJX-UHFFFAOYSA-M

InChI=1S/C15H17N2O2.BrH/c1-16(2)15(18)19-14-9-6-10-17(12-14)11-13-7-4-3-5-8-13;/h3-10,12H,11H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula	C15H17N2O2
Molecular Weight	257.3077
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	BrH
Molecular Weight	80.912
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://jamanetwork.com/journals/jama/article-abstract/309423 | https://www.drugfuture.com/chemdata/benzpyrinium-bromide.html

BENZPYRINIUM is a cholinergic drug used for prevention of postoperative intestinal atony, postoperative abdominal distention and urinary retention, or for treatment of postoperative distention.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Intestinal atony 2 Sources: https://jamanetwork.com/journals/jama/article-abstract/309423	Preventing		Approved 8583	Stigmonene bromide Approved Use For prevention of postoperative intestinal atony or postoperative abdominal distention and urinary retention; for treatment of postoperative distention.

Doses

Dose	Population	Adverse events
2 mg 3 times / 6 hours multiple, intramuscular Highest studied dose Dose: 2 mg, 3 times / 6 hours Route: intramuscular Route: multiple Dose: 2 mg, 3 times / 6 hours Sources: https://pubmed.ncbi.nlm.nih.gov/13084384/	unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: https://pubmed.ncbi.nlm.nih.gov/13084384/	Sources: https://pubmed.ncbi.nlm.nih.gov/13084384/

PubMed

Title	Date	PubMed
Stigmonene bromide in the treatment of muscular spasm.	1954-03	13221922
Stigmonene bromide in the diagnosis of early pregnancy and the treatment of simple delayed menstruation.	1952-10	12976381
Stigmonene bromide in the management of postoperative distention.	1951-10	14883044

Sample Use Guides

In Vivo Use Guide

0.5 mg by intramuscular injection.

Route of Administration: Intramuscular

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:23:46 GMT 2025` Edited by `admin` on `Mon Mar 31 18:23:46 GMT 2025`
Record UNII	X0L78YB79M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BENZPYRINIUM BROMIDE [MI]

Preferred Name

English

BENZPYRINIUM BROMIDE

Official Name

English

1-BENZYL-3-DIMETHYLCARBAMOYLOXYPYRIDINIUM BROMIDE

Systematic Name

English

benzpyrinium bromide [INN]

Common Name

English

1-BENZYL-3-HYDROXYPYRIDINIUM BROMIDE DIMETHYLCARBAMATE

Systematic Name

English

PYRIDINIUM, 1-BENZYL-3-HYDROXY-, BROMIDE, DIMETHYLCARBAMATE

Systematic Name

English

PYRIDINIUM, 1-BENZYL-3-DIMETHYLCARBAMOYLOXY-, BROMIDE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C47796